These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17669435)

  • 21. Effectiveness and safety of a treatment regimen based on isoniazid plus vaccination with Mycobacterium tuberculosis cells' fragments: field-study with naturally Mycobacterium caprae-infected goats.
    Domingo M; Gil O; Serrano E; Guirado E; Nofrarias M; Grassa M; Cáceres N; Pérez B; Vilaplana C; Cardona PJ
    Scand J Immunol; 2009 Jun; 69(6):500-7. PubMed ID: 19439010
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and management of latent tuberculosis infection.
    Hauck FR; Neese BH; Panchal AS; El-Amin W
    Am Fam Physician; 2009 May; 79(10):879-86. PubMed ID: 19496388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness analysis of optimal control measures for tuberculosis.
    Rodrigues P; Silva CJ; Torres DF
    Bull Math Biol; 2014 Oct; 76(10):2627-45. PubMed ID: 25245395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Managing TB in the 21st century: existing and novel drug therapies.
    Guy ES; Mallampalli A
    Ther Adv Respir Dis; 2008 Dec; 2(6):401-8. PubMed ID: 19124385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is susceptibility to tuberculosis acquired or inherited?
    Schurr E
    J Intern Med; 2007 Feb; 261(2):106-11. PubMed ID: 17241175
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Latent tuberculosis infection in children: a call for revised treatment guidelines.
    Finnell SM; Christenson JC; Downs SM
    Pediatrics; 2009 Mar; 123(3):816-22. PubMed ID: 19255008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies.
    Keane J; Bresnihan B
    Curr Opin Rheumatol; 2008 Jul; 20(4):443-9. PubMed ID: 18525359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Centenary of the Royal Dutch Central Association for the Prevention of Tuberculosis].
    Kuyvenhoven JV; Broekmans JF
    Ned Tijdschr Geneeskd; 2003 Sep; 147(38):1869-74. PubMed ID: 14533502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tuberculosis elimination in the Canadian First Nations population: assessment by a state-transfer, compartmental epidemic model.
    Clark M; Cameron DW
    Int J Infect Dis; 2009 Mar; 13(2):220-6. PubMed ID: 19185525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Surveillance of Mycobacterium tuberculosis resistance to antituberculosis drugs].
    Garzón MC; Angée DY; Llerena C; Orjuela DL; Victoria JE
    Biomedica; 2008 Sep; 28(3):319-26. PubMed ID: 19034356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tuberculosis in patients with HIV infection].
    Uriz J; Repáraz J; Castiello J; Sola J
    An Sist Sanit Navar; 2007; 30 Suppl 2():131-42. PubMed ID: 17898833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Anti-tuberculosis chemotherapy].
    Wada M
    Kekkaku; 2007 Oct; 82(10):771-81. PubMed ID: 18018601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The biosocial dynamics of tuberculosis.
    Grange JM; Kapata N; Chanda D; Mwaba P; Zumla A
    Trop Med Int Health; 2009 Feb; 14(2):124-30. PubMed ID: 19207176
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark.
    Hoff ST; Abebe M; Ravn P; Range N; Malenganisho W; Rodriques DS; Kallas EG; Søborg C; Mark Doherty T; Andersen P; Weldingh K
    Clin Infect Dis; 2007 Sep; 45(5):575-82. PubMed ID: 17682991
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The epidemiological consequences of leprosy-tuberculosis co-infection.
    Hohmann N; Voss-Böhme A
    Math Biosci; 2013 Feb; 241(2):225-37. PubMed ID: 23246805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New diagnostics for latent and active tuberculosis: state of the art and future prospects.
    Pai M; O'Brien R
    Semin Respir Crit Care Med; 2008 Oct; 29(5):560-8. PubMed ID: 18810689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mathematical modeling of the cause of tuberculosis during tumor necrosis factor blockade.
    Wallis RS
    Arthritis Rheum; 2008 Apr; 58(4):947-52. PubMed ID: 18383389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population.
    Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M
    J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Monitoring of tuberculosis recurrences: their causes and precipitating factors].
    Skachkova EI; Nechaeva OB; Aref'eva EV; Iasinetskaia NV
    Probl Tuberk Bolezn Legk; 2008; (8):16-9. PubMed ID: 18819332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review article: minimizing tuberculosis during anti-tumour necrosis factor-alpha treatment of inflammatory bowel disease.
    Theis VS; Rhodes JM
    Aliment Pharmacol Ther; 2008 Jan; 27(1):19-30. PubMed ID: 17944997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.